Prognostic significance of Epstein-Barr virus association in Hodgkin's disease
- 1 January 1994
- journal article
- other
- Published by Elsevier in European Journal Of Cancer
- Vol. 30 (7) , 1045-1046
- https://doi.org/10.1016/0959-8049(94)90157-0
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Influence of Epstein–Barr Virus Genomes on Patient Survival in Hodgkin’s DiseaseAmerican Journal of Clinical Pathology, 1992
- The expression of the EBV latent membrane protein (LMP‐1) is independent of CD23 and bcl‐2 in Reed‐Sternberg cells in Hodgkin's diseaseHistopathology, 1992
- Prognosis of Hodgkin's disease in not influenced by epstein‐barry virus latent membrane proteinInternational Journal of Cancer, 1992
- Detection of Epstein-Barr virus genomes in Hodgkin's disease: relation to age.Journal of Clinical Pathology, 1991
- A numerical prognostic index for clinical use in identification of poor-risk patients with Hodgkin's disease at diagnosisEuropean Journal of Cancer and Clinical Oncology, 1991
- Expression of Epstein-Barr virus latent gene products in tumour cells of Hodgkin's diseaseThe Lancet, 1991
- Survival of the older patient compared with the younger patient with hodgkin's disease. Influence of histologic type, staging, and treatmentCancer, 1990